|
HEATR5A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.58290000498818E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.82390000272414E-09 |
| Normal-vs-Stage2 |
1.031410E-04 |
| Normal-vs-Stage3 |
7.598500E-03 |
| Normal-vs-Stage4 |
1.64979999994763E-06 |
| Stage1-vs-Stage2 |
7.413800E-01 |
| Stage1-vs-Stage3 |
4.259400E-01 |
| Stage1-vs-Stage4 |
3.530200E-01 |
| Stage2-vs-Stage3 |
7.458200E-01 |
| Stage2-vs-Stage4 |
1.980170E-01 |
| Stage3-vs-Stage4 |
2.196200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54869994606344E-09 |
| Normal-vs-AfricanAmerican |
4.72709999999044E-06 |
| Normal-vs-Asian |
5.610400E-04 |
| Caucasian-vs-AfricanAmerican |
9.849600E-01 |
| Caucasian-vs-Asian |
7.424000E-01 |
| AfricanAmerican-vs-Asian |
7.698800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17009751782393E-11 |
| Normal-vs-Female |
2.773800E-02 |
| Male-vs-Female |
3.822200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.950400E-04 |
| Normal-vs-Extreme_Weight |
5.00960384286486E-11 |
| Normal-vs-Obese |
1.427760E-04 |
| Normal-vs-Extreme_Obese |
4.45290000000709E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.480200E-01 |
| Normal_Weight-vs-Obese |
4.990600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.759400E-01 |
| Extreme_Weight-vs-Obese |
4.891800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.742200E-01 |
| Obese-vs-Extreme_Obese |
4.107200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.871200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.89240000003643E-06 |
| Normal-vs-Age(61-80Yrs) |
8.01619881585225E-11 |
| Normal-vs-Age(81-100Yrs) |
1.67179999954747E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.868400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.788040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.188500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.184000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.299200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.700400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.56879970020429E-10 |
| Normal-VS-Type2 PRCC |
4.64820000001254E-06 |
| Normal-VS-KIRP CIMP |
8.430000E-01 |
| Normal-VS-Unclassified PRCC |
1.054110E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.055200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.456600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.944300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.775800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.551200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.114400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.44789999381823E-09 |
| Normal-vs-N1 |
7.576000E-02 |
| Normal-vs-N2 |
2.32239999999884E-05 |
| N0-vs-N1 |
1.779020E-01 |
| N0-vs-N2 |
3.315200E-01 |
| N1-vs-N2 |
2.841400E-01 |
|
|
